Sun Pharma on Thursday reported 123 per cent year-on-year increase in consolidated net profit at Rs 894 crore for the quarter ending March 31, 2021. It was Rs 399.8 crore in the year-ago period.
However, the profit was still below the Street's expectation of over Rs 1,200 crore on account of exceptional loss worth Rs 672.8 crore related to various litigation settlements pertaining to some of its subsidiaries.
Sun Pharma said the adjusted net profit came in at Rs 1,343 crore, up 103 per cent year-on-year.
Its revenue from operations came in at Rs 8,522 crore for the quarter under